Free Trial

Sintx Technologies (SINT) Competitors

Sintx Technologies logo
$2.72 -0.03 (-1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$2.70 -0.02 (-0.74%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SINT vs. CLGN, ALUR, IRIX, BDMD, OSRH, PETV, RVP, NRXS, PSTV, and NXL

Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include CollPlant Biotechnologies (CLGN), Allurion Technologies (ALUR), IRIDEX (IRIX), Baird Medical Investment (BDMD), OSR (OSRH), PetVivo (PETV), Retractable Technologies (RVP), NeurAxis (NRXS), Plus Therapeutics (PSTV), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.

Sintx Technologies vs. Its Competitors

Sintx Technologies (NASDAQ:SINT) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 0.0% of Sintx Technologies shares are owned by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Sintx Technologies and Sintx Technologies both had 1 articles in the media. Sintx Technologies' average media sentiment score of 0.00 equaled CollPlant Biotechnologies'average media sentiment score.

Company Overall Sentiment
Sintx Technologies Neutral
CollPlant Biotechnologies Neutral

Sintx Technologies has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Sintx Technologies presently has a consensus price target of $28.00, indicating a potential upside of 929.41%. CollPlant Biotechnologies has a consensus price target of $11.50, indicating a potential upside of 375.21%. Given Sintx Technologies' higher probable upside, analysts plainly believe Sintx Technologies is more favorable than CollPlant Biotechnologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
CollPlant Biotechnologies
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Sintx Technologies has a net margin of -483.85% compared to CollPlant Biotechnologies' net margin of -560.92%. CollPlant Biotechnologies' return on equity of -87.33% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-483.85% -203.66% -104.76%
CollPlant Biotechnologies -560.92%-87.33%-65.31%

Sintx Technologies has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$2.89M2.36-$11.02M-$50.56-0.05
CollPlant Biotechnologies$510K60.36-$16.61M-$1.22-1.98

Summary

CollPlant Biotechnologies beats Sintx Technologies on 10 of the 15 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

MetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$6.90M$6.86B$5.70B$9.48B
Dividend YieldN/A1.27%4.59%3.99%
P/E Ratio-0.0525.4327.9019.95
Price / Sales2.3650.22442.19102.72
Price / CashN/A20.6736.5558.97
Price / Book0.944.728.635.90
Net Income-$11.02M$176.14M$3.24B$258.42M
7 Day Performance-1.81%1.68%3.22%1.94%
1 Month Performance-12.54%3.77%10.72%12.02%
1 Year Performance-46.46%6.45%34.94%20.81%

Sintx Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
2.9855 of 5 stars
$2.72
-1.1%
$28.00
+929.4%
-46.2%$6.90M$2.89M-0.0540
CLGN
CollPlant Biotechnologies
1.8704 of 5 stars
$2.24
+10.3%
$11.50
+413.4%
-50.3%$25.81M$510K-1.8470Gap Down
High Trading Volume
ALUR
Allurion Technologies
2.978 of 5 stars
$3.17
+0.8%
$22.83
+621.4%
-85.3%$23.42M$32.11M-0.25501
IRIX
IRIDEX
0.481 of 5 stars
$1.26
flat
N/A-31.5%$21.15M$48.67M-2.93120News Coverage
High Trading Volume
BDMD
Baird Medical Investment
N/A$3.06
-1.9%
N/AN/A$20.54MN/A0.00N/AGap Up
OSRH
OSR
N/A$1.08
+1.9%
N/AN/A$20.43MN/A0.00N/ANews Coverage
Gap Up
PETV
PetVivo
N/A$0.83
+3.9%
N/A+33.5%$20.29M$1.05M-1.8520High Trading Volume
RVP
Retractable Technologies
2.0575 of 5 stars
$0.66
+0.5%
N/A-37.6%$19.88M$33.75M-1.23240News Coverage
NRXS
NeurAxis
2.5495 of 5 stars
$2.73
+4.2%
$7.00
+156.4%
-11.5%$19.70M$2.93M-1.4819
PSTV
Plus Therapeutics
1.6241 of 5 stars
$0.38
+3.4%
$10.83
+2,721.2%
-72.0%$18.95M$5.82M-0.1320News Coverage
Gap Up
NXL
Nexalin Technology
2.2551 of 5 stars
$1.20
+10.1%
$5.00
+316.7%
-0.8%$18.72M$170K-1.453

Related Companies and Tools


This page (NASDAQ:SINT) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners